Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Jiahao Li, Rujia Zhong, Yi Guo, Feng Zhan. Eye disorders associated with selective serotonin reuptake inhibitors: a real-world disproportionality analysis of FDA adverse event reporting system. Expert opinion on drug safety. 2024-07-25. PMID:39051730. |
selective serotonin reuptake inhibitors (ssris) are widely used in depression and other psychiatric disorders. |
2024-07-25 |
2024-07-28 |
Not clear |
Mengjie Su, Wenjing Peng, Zhengyuan Ding, Yaqiu Zhou, Hui Gao, Qiyu Jiang, Chunmei Y. Multi-walled carbon nanotubes-metal-organic framework nanocomposite based sensor for the monitoring of multiple monoamine neurotransmitters in living cells. Bioelectrochemistry (Amsterdam, Netherlands). vol 160. 2024-07-17. PMID:39018612. |
the levels of monoamine neurotransmitters (mnts) including dopamine (da), adrenaline (adr), norepinephrine (ne) and 5-hydroxytryptamine (5-ht) in cells are useful indicators to explore the pathogenesis of mnts-related diseases such as alzheimer's disease, parkinson's disease and depression. |
2024-07-17 |
2024-07-20 |
Not clear |
Lizhou Yue, Huawei Huang, Weiying Li. Development of a Highly Specific Fluorescent Probe based on Thiol-ene Click Nucleophilic Cascade Reactions for Delving into the Action Mechanism of Serotonin in Depression. Angewandte Chemie (International ed. in English). 2024-07-12. PMID:38995157. |
development of a highly specific fluorescent probe based on thiol-ene click nucleophilic cascade reactions for delving into the action mechanism of serotonin in depression. |
2024-07-12 |
2024-07-14 |
Not clear |
Lizhou Yue, Huawei Huang, Weiying Li. Development of a Highly Specific Fluorescent Probe based on Thiol-ene Click Nucleophilic Cascade Reactions for Delving into the Action Mechanism of Serotonin in Depression. Angewandte Chemie (International ed. in English). 2024-07-12. PMID:38995157. |
the intrinsic correlation between depression and serotonin (5-ht) is a highly debated topic, with significant implications for the diagnosis, treatment, and advancement of drugs targeting neurological disorders. |
2024-07-12 |
2024-07-14 |
Not clear |
Lizhou Yue, Huawei Huang, Weiying Li. Development of a Highly Specific Fluorescent Probe based on Thiol-ene Click Nucleophilic Cascade Reactions for Delving into the Action Mechanism of Serotonin in Depression. Angewandte Chemie (International ed. in English). 2024-07-12. PMID:38995157. |
to address this important question, it is of utmost priority to understand the action mechanism of serotonin in depression through fluorescence imaging studies. |
2024-07-12 |
2024-07-14 |
Not clear |
Lizhou Yue, Huawei Huang, Weiying Li. Development of a Highly Specific Fluorescent Probe based on Thiol-ene Click Nucleophilic Cascade Reactions for Delving into the Action Mechanism of Serotonin in Depression. Angewandte Chemie (International ed. in English). 2024-07-12. PMID:38995157. |
the novel responsive site was then employed to construct the powerful molecular probe sj-5-ht for imaging the serotonin level changes in the depression cells and brain tissues. |
2024-07-12 |
2024-07-14 |
Not clear |
Lizhou Yue, Huawei Huang, Weiying Li. Development of a Highly Specific Fluorescent Probe based on Thiol-ene Click Nucleophilic Cascade Reactions for Delving into the Action Mechanism of Serotonin in Depression. Angewandte Chemie (International ed. in English). 2024-07-12. PMID:38995157. |
importantly, the imaging studies reveal that the level of serotonin in patients with depression may not be the primary factor, while the ability of neurons in patients with depression to release serotonin appears to be more critical. |
2024-07-12 |
2024-07-14 |
Not clear |
Jenessa N Johnston, Carlos A Zarate, Mark D Kvart. Esketamine in depression: putative biomarkers from clinical research. European archives of psychiatry and clinical neuroscience. 2024-07-12. PMID:38997425. |
esketamine also shows promise in perioperative settings for reducing depression and anxiety, and these effects appear to correlate with increased peripheral biomarkers such as brain-derived neurotrophic factor and serotonin. |
2024-07-12 |
2024-07-15 |
Not clear |
María Sancho-Alonso, Unai Sarriés-Serrano, Lluis Miquel-Rio, Claudia Yanés, Verónica Paz, J Javier Meana, Mario Perello, Analia Bortolozz. New insights into the effects of serotonin on Parkinson's disease and depression through its role in the gastrointestinal tract. Spanish journal of psychiatry and mental health. 2024-07-11. PMID:38992345. |
new insights into the effects of serotonin on parkinson's disease and depression through its role in the gastrointestinal tract. |
2024-07-11 |
2024-07-14 |
Not clear |
Wael Y Khawagi, Hayder M Al-Kuraishy, Nawar R Hussein, Ali I Al-Gareeb, Esraa Atef, Omnya Elhussieny, Athanasios Alexiou, Marios Papadakis, Majid S Jabir, Abdullah A Alshehri, Hebatallah M Saad, Gaber El-Saber Batih. Depression and type 2 diabetes: A causal relationship and mechanistic pathway. Diabetes, obesity & metabolism. vol 26. issue 8. 2024-07-09. PMID:38802993. |
hyperglycaemia and dyslipidaemia promote the incidence of depression by enhancing inflammation and reducing brain serotonin (5-hydroxytryptamine [5ht]). |
2024-07-09 |
2024-07-12 |
Not clear |
Wael Y Khawagi, Hayder M Al-Kuraishy, Nawar R Hussein, Ali I Al-Gareeb, Esraa Atef, Omnya Elhussieny, Athanasios Alexiou, Marios Papadakis, Majid S Jabir, Abdullah A Alshehri, Hebatallah M Saad, Gaber El-Saber Batih. Depression and type 2 diabetes: A causal relationship and mechanistic pathway. Diabetes, obesity & metabolism. vol 26. issue 8. 2024-07-09. PMID:38802993. |
dysregulation of insulin signalling in t2d impairs brain 5ht signalling, leading to the development of depression. |
2024-07-09 |
2024-07-12 |
Not clear |
Yu-Long Zhao, Hui-Yuan Yi, Sani Sa'idu Baba, Yi-Xiao Guo, Xiao-Cui Yuan, Xue-Mei Hou, Ling-Li Liang, Fu-Quan Hu. Activation of 5-HT Molecular neurobiology. 2024-07-04. PMID:38963532. |
activation of 5-ht the comorbidity of anxiety and depression frequently occurs in patients with neuropathic pain. |
2024-07-04 |
2024-07-10 |
Not clear |
Yundeng Xiaowen, Jingxuan Zhu, Mingming Gong, Ge Meng, Renran Tan, Yanbing Zhang, Zhiyu Che. Effect of depression and the antidepressant fluoxetine on osseointegration-A pre-clinical in vivo experimental study. Clinical oral implants research. 2024-07-04. PMID:38963167. |
the aim of this study was to explore the effect of depression and selective serotonin reuptake inhibitors on implant osseointegration and bone healing. |
2024-07-04 |
2024-07-10 |
Not clear |
Renjie Gao, Panpan Zhao, Kai Ya. Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis. Clinical drug investigation. 2024-07-03. PMID:38960993. |
selective serotonin reuptake inhibitors for the treatment of depression in parkinson's disease: a systematic review and meta-analysis. |
2024-07-03 |
2024-07-10 |
Not clear |
Vincenzo Cardaci, Matteo Carminati, Mattia Tondello, Basilio Pecorino, Alessandro Serretti, Raffaella Zanard. Understanding and treating postpartum depression: a narrative review. International clinical psychopharmacology. 2024-06-28. PMID:38941162. |
treatment may differ from the traditional major depression management, while selective serotonin reuptake inhibitors such as sertraline are commonly used and suggested by guidelines, neurosteroids such as brexanolone and the more convenient zuranolone have been recently approved. |
2024-06-28 |
2024-07-01 |
Not clear |
Cem Yamali, Merve Nenni, Mehtap Tugrak Sakarya, Hasan Alper Kapla. Pharmaceutical Studies on Piperazine-Based Compounds Targeting Serotonin Receptors and Serotonin Reuptake Transporters. Mini reviews in medicinal chemistry. 2024-06-24. PMID:38910275. |
gene polymorphisms related to 5-hydroxytryptamine (5-ht) signaling and subtypes of 5-ht receptors may play a role in the development of depression and the response to antidepressants. |
2024-06-24 |
2024-06-26 |
Not clear |
Cem Yamali, Merve Nenni, Mehtap Tugrak Sakarya, Hasan Alper Kapla. Pharmaceutical Studies on Piperazine-Based Compounds Targeting Serotonin Receptors and Serotonin Reuptake Transporters. Mini reviews in medicinal chemistry. 2024-06-24. PMID:38910275. |
ssris binding to 5-ht reuptake transporters help relieve depression symptoms. |
2024-06-24 |
2024-06-26 |
Not clear |
Arman Shafiee, Kyana Jafarabady, Niloofar Seighali, Ida Mohammadi, Shahryar Rajai Firouz Abadi, Faeze Soltani Abhari, Mahmood Bakhtiyar. Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials. Nutrition reviews. 2024-06-24. PMID:38913392. |
effect of saffron versus selective serotonin reuptake inhibitors (ssris) in treatment of depression and anxiety: a meta-analysis of randomized controlled trials. |
2024-06-24 |
2024-06-26 |
Not clear |
Maurizio Bossola, Ilaria Mariani, Manuela Antocicco, Gilda Pepe, Anna Petrosino, Enrico Di Stasi. Selective Serotonin Reuptake Inhibitors and Symptoms of Depression in Patients on Chronic Hemodialysis: A Systematic Review. Journal of clinical medicine. vol 13. issue 11. 2024-06-19. PMID:38893046. |
selective serotonin reuptake inhibitors and symptoms of depression in patients on chronic hemodialysis: a systematic review. |
2024-06-19 |
2024-06-21 |
Not clear |
Hanan S Althagafy, Emad H M Hassanei. Fluoxetine attenuates chlorpyrifos-induced neuronal injury through the PPARγ, SIRT1, NF-κB, and JAK1/STAT3 signals. International immunopharmacology. vol 136. 2024-06-15. PMID:38815349. |
fluoxetine (flx) is a selective serotonin reuptake inhibitor (ssri) that is widely prescribed for depression and anxiety disorders. |
2024-06-15 |
2024-06-18 |
rat |